An Analysis of the Catalytic Cycle of HIV-1 Reverse Transcriptase Opportunities for Chemotherapeutic Intervention Based on Enzyme Inhibition

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|6|5|547-567

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.6, Iss.5, 2000-03, pp. : 547-567

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structural Aspects of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibition

Current Computer - Aided Drug Design, Vol. 3, Iss. 2, 2007-06 ,pp. : 87-100

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 reverse transcriptase inhibitors

By Krawczyk Sören Hilgeroth Andreas

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 270-276

Govi-Verlag

Access to resources Recommend Favorite

Design, Synthesis and Pharmacological Evaluation of HIV-1 Reverse Transcriptase Inhibition of New Indolin-2-Ones

Medicinal Chemistry, Vol. 3, Iss. 6, 2007-11 ,pp. : 533-542

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Thiazolidinone Derivatives with an Uncommon Mechanism of Inhibition Towards HIV-1 Reverse Transcriptase

Letters in Drug Design & Discovery, Vol. 7, Iss. 4, 2010-05 ,pp. : 228-234

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 Reverse Transcriptase: A Therapeutical Target in the Spotlight

Current Medicinal Chemistry, Vol. 13, Iss. 3, 2006-02 ,pp. : 313-324

Bentham Science Publishers

Access to resources Recommend Favorite